Guoyang Wu

622 citations
32 papers · 452 indexed · h-index 11
Topics
Thyroid and Parathyroid Surgery (13 papers)Head and Neck Anomalies (9 papers)Thyroid Cancer Diagnosis and Treatment (8 papers)

In The Last Decade

Guoyang Wu

31 papers receiving 445 citations

Peers

Guoyang Wu
Comparison fields: 5 of 68
  • Molecular Biology 159
  • Surgery 144
  • Cancer Research 100
  • Oncology 94
  • Epidemiology 93
Replace Jun Tomoda with:
Jun Tomoda Japan
Ting Chang United States
Rongqiang Liu China
Markus Büchler Germany
Piotr Spychalski Poland
Yuchong Zhao China
Kaoru Iwata Japan
Nicholas Nissen United States
Balázs Járay Hungary
Dominic Poulin Canada
Guoyang Wu relative to Jun Tomoda Japan Jun Tomoda's profile →
Citations per field
00.5×2.9×
Jun Tomoda · 1×
Citations per year

Countries citing papers authored by Guoyang Wu

Since Specialization
Citations

This map shows the geographic impact of Guoyang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoyang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoyang Wu more than expected).

Fields of papers citing papers by Guoyang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoyang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoyang Wu. The network helps show where Guoyang Wu may publish in the future.

Co-authorship network of co-authors of Guoyang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoyang Wu. A scholar is included among the top collaborators of Guoyang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoyang Wu. Guoyang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 5
4 1
5 6
6 3
7 13
8 17
9 4
10 8
11 10
12 1
13 52
14 33
15 12
16 6
17 3
18 2
19 16
20
[Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage].
2

About Guoyang Wu

Guoyang Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 32 papers that have together received 452 indexed citations. Recurring topics across this work include Thyroid and Parathyroid Surgery (13 papers), Head and Neck Anomalies (9 papers) and Thyroid Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Hepatology (72 citations), Cancer Research (100 citations) and Anesthesiology and Pain Medicine (30 citations). Guoyang Wu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Michael Keese, Till Hasenberg, Jörg W. Sturm, Richard Magdeburg, Wei Yan, Wei Yan, Yuanyuan Wang, Lee F. Peng, Wenyu Lin and Wen‐Chi Chen. Their work appears in journals such as Journal of Biological Chemistry, Analytical Chemistry and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026